Literature DB >> 16648850

A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization.

Dan E Arking1, Arne Pfeufer, Wendy Post, W H Linda Kao, Christopher Newton-Cheh, Morna Ikeda, Kristen West, Carl Kashuk, Mahmut Akyol, Siegfried Perz, Shapour Jalilzadeh, Thomas Illig, Christian Gieger, Chao-Yu Guo, Martin G Larson, H Erich Wichmann, Eduardo Marbán, Christopher J O'Donnell, Joel N Hirschhorn, Stefan Kääb, Peter M Spooner, Thomas Meitinger, Aravinda Chakravarti.   

Abstract

Extremes of the electrocardiographic QT interval, a measure of cardiac repolarization, are associated with increased cardiovascular mortality. We identified a common genetic variant influencing this quantitative trait through a genome-wide association study on 200 subjects at the extremes of a population-based QT interval distribution of 3,966 subjects from the KORA cohort in Germany, with follow-up screening of selected markers in the remainder of the cohort. We validated statistically significant findings in two independent samples of 2,646 subjects from Germany and 1,805 subjects from the US Framingham Heart Study. This genome-wide study identified NOS1AP (CAPON), a regulator of neuronal nitric oxide synthase, as a new target that modulates cardiac repolarization. Approximately 60% of subjects of European ancestry carry at least one minor allele of the NOS1AP genetic variant, which explains up to 1.5% of QT interval variation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16648850     DOI: 10.1038/ng1790

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  232 in total

1.  Common genetic variants, QT interval, and sudden cardiac death in a Finnish population-based study.

Authors:  Peter A Noseworthy; Aki S Havulinna; Kimmo Porthan; Annukka M Lahtinen; Antti Jula; Pekka J Karhunen; Markus Perola; Lasse Oikarinen; Kimmo K Kontula; Veikko Salomaa; Christopher Newton-Cheh
Journal:  Circ Cardiovasc Genet       Date:  2011-04-21

2.  Advanced molecular biologic techniques in toxicologic disease.

Authors:  Jeanine Ward; Gyongyi Szabo; David McManus; Edward Boyer
Journal:  J Med Toxicol       Date:  2011-12

3.  Epidemiology and genetics of sudden cardiac death.

Authors:  Rajat Deo; Christine M Albert
Journal:  Circulation       Date:  2012-01-31       Impact factor: 29.690

4.  Bump hunting to identify differentially methylated regions in epigenetic epidemiology studies.

Authors:  Andrew E Jaffe; Peter Murakami; Hwajin Lee; Jeffrey T Leek; M Daniele Fallin; Andrew P Feinberg; Rafael A Irizarry
Journal:  Int J Epidemiol       Date:  2012-02       Impact factor: 7.196

5.  A common variant in SLC8A1 is associated with the duration of the electrocardiographic QT interval.

Authors:  Jong Wook Kim; Kyung-Won Hong; Min Jin Go; Sung Soo Kim; Yasuharu Tabara; Yoshikuni Kita; Takeshi Tanigawa; Yoon Shin Cho; Bok-Ghee Han; Bermseok Oh
Journal:  Am J Hum Genet       Date:  2012-06-21       Impact factor: 11.025

6.  From Fifth Business to Protagonist: the complex roles of ion channel anchors in cardiac arrhythmia.

Authors:  Crystal F Kline; Peter J Mohler
Journal:  Drug Discov Today Dis Models       Date:  2009-09-01

7.  Systems pharmacology of arrhythmias.

Authors:  Seth I Berger; Avi Ma'ayan; Ravi Iyengar
Journal:  Sci Signal       Date:  2010-04-20       Impact factor: 8.192

Review 8.  Genetics of sudden cardiac death caused by ventricular arrhythmias.

Authors:  Roos F Marsman; Hanno L Tan; Connie R Bezzina
Journal:  Nat Rev Cardiol       Date:  2013-12-10       Impact factor: 32.419

9.  Determinants of prolonged QT interval and their contribution to sudden death risk in coronary artery disease: the Oregon Sudden Unexpected Death Study.

Authors:  Sumeet S Chugh; Kyndaron Reinier; Tejwant Singh; Audrey Uy-Evanado; Carmen Socoteanu; Dawn Peters; Ronald Mariani; Karen Gunson; Jonathan Jui
Journal:  Circulation       Date:  2009-01-26       Impact factor: 29.690

10.  A common NOS1AP genetic polymorphism is associated with increased cardiovascular mortality in users of dihydropyridine calcium channel blockers.

Authors:  Matthijs L Becker; Loes E Visser; Christopher Newton-Cheh; Albert Hofman; André G Uitterlinden; Jacqueline C M Witteman; Bruno H Ch Stricker
Journal:  Br J Clin Pharmacol       Date:  2008-11-17       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.